Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in OKUR — OnKure Therapeutics, Inc.

CIK 1423053 MIAMI, FL
Back to OKUR Full portfolio

Position in OKUR

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$5,412,934
+$5,257,324 QoQ
Shares Held
1,187,047
+3058.1% QoQ
Ownership
2.93%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 75 holders
Holding Since
Jun 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OKUR Over Time

Shares Held

Position Value (USD)

Derivatives in OKUR

reported options exposure · as of Mar 31, 2024
CallValue
$0
CallShares
2,800
PutValue
$0
PutShares
3,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. OKUR ranks #133 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in OKUR

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,412,934 1,187,047
2026-03-31 $155,610 37,587
2025-12-31 $647,062 223,125
2025-09-30 $2,795,685 1,016,613
2025-06-30 $2,603,450 1,089,310
2025-03-31 $4,592,846 1,068,104
2024-12-31 $9,239,099 1,074,314